Company intelligence / Profile preview

Genevolve

India

Ownership: Private
Development stage: Other

Overview

Genevolve serves as the genomics division of Dr. Lal PathLabs Limited, delivering high-throughput DNA-based diagnostics and precision medicine services in India. It has rapidly established a leading reputation for clinical diagnostics, research collaborations, and personalized healthcare, leveraging state-of-the-art sequencing (NovaSeq X Series) and AI-enabled analysis. The division is fully commercial and active, but does not appear to have therapeutics in clinical development stages.[1][2]

Modalities: High-throughput genomic sequencingNext-generation sequencingDNA diagnostics
Industry: Molecular Diagnostics

Partnerships

IlluminaPremas Life Sciences

Beyond the preview

Go deeper on Genevolve.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genevolve.

Explore the full profile